Primary prevention of cardiovascular disease with hormone replacement therapy

12 Citations (Scopus)


Many peri- and postmenopausal women suffer from a reduced quality of life due to menopausal symptoms and preventable diseases. The importance of cardiovascular disease in women must be emphasized, as it is the leading cause of mortality and morbidity in women. It is well known that female hormones contribute to the later onset of cardiovascular disease in women. The effect of estrogens has for decades been understood from observational studies of postmenopausal women treated with hormone replacement therapy (HRT). Later, treatment with HRT was disregarded due to the fear of side-effects and an ambiguity of the cardiovascular advantages. Accumulating knowledge from the large number of trials and studies has elucidated the cause for the disparity in results. In this paper, the beneficial effects of HRT, with emphasis on cardiovascular disease are explained, and the relative and absolute risks of side-effects are discussed.

Original languageEnglish
JournalClimacteric : the journal of the International Menopause Society
Issue number4
Pages (from-to)492-7
Number of pages6
Publication statusPublished - 2015


Dive into the research topics of 'Primary prevention of cardiovascular disease with hormone replacement therapy'. Together they form a unique fingerprint.

Cite this